Inducing Synthetic Lethality using PARP Inhibitors

Publisher： Bentham Science Publishers

E-ISSN： 2212-3938|5|3|192-195

ISSN： 1574-8847

Source： Current Clinical Pharmacology, Vol.5, Iss.3, 2010-08, pp. : 192-195

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Synthetic Lethality and PARP-Inhibitors in Oral and Head & Neck Cancer

By  

Current Pharmaceutical Design, Vol. 18, Iss. 34, 2012-11 ,pp. : 5431-5441

Bentham Science Publishers

Access to resources Recommend Favorite

Development of PARP inhibitors in oncology

By Rodon Jordi   Iniesta Maria D   Papadopoulos Kyriakos  

Expert Opinion on Investigational Drugs, Vol. 18, Iss. 1, 2009-01 ,pp. : 31-43

Informa Healthcare

Access to resources Recommend Favorite

Discussion of PARP inhibitors in cancer therapy

By Wielgos Monica   Yang Eddy S  

Pharmaceutical Patent Analyst, Vol. 2, Iss. 6, 2013-11 ,pp. : 755-766

Future Science

Access to resources Recommend Favorite

PARP inhibitors in cancer therapy: an update

By Papeo Gianluca   Casale Elena   Montagnoli Alessia   Cirla Alessandra  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 4, 2013-04 ,pp. : 503-514

Informa Healthcare

Access to resources Recommend Favorite

Parp Inhibitors for the Treatment of Ovarian Cancer

By  

Current Cancer Drug Targets, Vol. 18, Iss. 9, 2018-11 ,pp. : 877-893

Bentham Science Publishers

Access to resources Recommend Favorite